Prosthesis-Patient Mismatch Following Transcatheter Aortic Valve Replacement With Supra-Annular and Intra-Annular Prostheses.


Journal

JACC. Cardiovascular interventions
ISSN: 1876-7605
Titre abrégé: JACC Cardiovasc Interv
Pays: United States
ID NLM: 101467004

Informations de publication

Date de publication:
11 11 2019
Historique:
received: 21 05 2019
revised: 15 07 2019
accepted: 17 07 2019
pubmed: 1 10 2019
medline: 29 9 2020
entrez: 1 10 2019
Statut: ppublish

Résumé

This study sought to compare the frequency of prosthesis-patient mismatch (PPM) with self-expandable valves (SEV) to balloon-expandable valves (BEV). PPM has been associated with increased mortality after transcatheter aortic valve replacement. Data on the frequency of PPM as a function of supra-annular or intra-annular position of transcatheter heart valves are insufficient. A total of 757 patients treated with SEV (CoreValve, Evolut R) and BEV (SAPIEN THV/XT/3) were enrolled in the present analysis between August 2007 and June 2017. PPM was classified based on discharge prosthetic effective orifice area indexed to body surface area (BSA) as severe (<0.65 cm Propensity score matching resulted in 224 matched pairs. At discharge, SEV were associated with a lower incidence of PPM compared with BEV (PPM, 33.5% vs. 46.9%; p = 0.004; severe PPM, 6.7% vs. 15.6%; p = 0.003). The lower frequency of severe PPM in SEV was observed even in patients with larger annulus. Although patients with BSA >1.83 m SEV were associated with a lower frequency of PPM compared with BEV irrespective of annulus area. The difference was mainly driven by larger patients with BSA >1.83 m

Sections du résumé

OBJECTIVES
This study sought to compare the frequency of prosthesis-patient mismatch (PPM) with self-expandable valves (SEV) to balloon-expandable valves (BEV).
BACKGROUND
PPM has been associated with increased mortality after transcatheter aortic valve replacement. Data on the frequency of PPM as a function of supra-annular or intra-annular position of transcatheter heart valves are insufficient.
METHODS
A total of 757 patients treated with SEV (CoreValve, Evolut R) and BEV (SAPIEN THV/XT/3) were enrolled in the present analysis between August 2007 and June 2017. PPM was classified based on discharge prosthetic effective orifice area indexed to body surface area (BSA) as severe (<0.65 cm
RESULTS
Propensity score matching resulted in 224 matched pairs. At discharge, SEV were associated with a lower incidence of PPM compared with BEV (PPM, 33.5% vs. 46.9%; p = 0.004; severe PPM, 6.7% vs. 15.6%; p = 0.003). The lower frequency of severe PPM in SEV was observed even in patients with larger annulus. Although patients with BSA >1.83 m
CONCLUSIONS
SEV were associated with a lower frequency of PPM compared with BEV irrespective of annulus area. The difference was mainly driven by larger patients with BSA >1.83 m

Identifiants

pubmed: 31564593
pii: S1936-8798(19)31542-0
doi: 10.1016/j.jcin.2019.07.027
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2173-2182

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Auteurs

Taishi Okuno (T)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Faisal Khan (F)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Masahiko Asami (M)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Fabien Praz (F)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Dik Heg (D)

Clinical Trials Unit, University of Bern, Bern, Switzerland.

Mirjam Gauri Winkel (MG)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Jonas Lanz (J)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Adrian Huber (A)

Department of Diagnostic, Interventional and Pediatric Radiology, Inselspital, University of Bern, Bern, Switzerland.

Christoph Gräni (C)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Lorenz Räber (L)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Stefan Stortecky (S)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Marco Valgimigli (M)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Stephan Windecker (S)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland.

Thomas Pilgrim (T)

Department of Cardiology, Inselspital, University of Bern, Bern, Switzerland. Electronic address: thomas.pilgrim@insel.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH